Net Sales: Increased by 2.9% at constant exchange rates to CHF11.1 billion in 2025. Core EBIT: Amounted to CHF349 million, a 6.7% increase from 2024, with a margin increase from 3.1% to 3.2%. Free ...

DKSH Holding AG’s stock price rose by 4.65% following the company’s H2 2025 earnings call, driven by a 2.9% increase in net sales at constant exchange rates to 11.1 billion CHF and a 6.7% rise in core ...

DKSH Holding AG (SIX:DKSH) presented its full-year 2025 results on February 17, 2026, showcasing solid performance with accelerated growth in the second half of the year. The Swiss market expansion ...

Fintel reports that on January 5, 2025, BNP PARIBAS EXANE upgraded their outlook for DKSH Holding (SWX:DKSH) from Neutral to Outperform. As of December 23, 2024, the average one-year price target for ...

DKSH Holding AG Annual cash flow by MarketWatch. View DKSH net cash flow, operating cash flow, operating expenses and cash dividends.

Bhd has concluded that the company's proposed privatisation is "not fair but reasonable", and has advised minority ...

(RTTNews) - DKSH Holding AG (DKSH.SW, DKSHF), a market expansion services company, on Wednesday announced that it has signed an agreement to acquire Biomedic, a Vietnam-based distributor of diagnostic ...

DKSH Technology Strengthens its Korean Business with the Acquisition of MDxK 26.03.2025 / 07:00 CET/CEST Media release DKSH has signed an agreement to acquire Molecular Diagnostics Korea Inc. (“MDxK”) ...

Looking for the most shorted stocks?

DKSH Holding AG, the Zurich-based distribution firm, is among bidders vying to acquire Swiss drug distribution company Swixx Biopharma SA, according to people familiar with the matter. Swixx has also ...